(Press-News.org) A new study led by researchers from the Oxford University Museum of Natural History, University of Oxford and the University of Birmingham for Current Biology has used new methods to analyse the variability of mammal fossils, revealing extraordinary results: it was not dinosaurs, but possibly other mammals, that were the main competitors of modern mammals before and after the mass extinction of dinosaurs.
The study challenges old assumptions about why mammals only seemed to diversify, becoming larger and exploring new diets, locomotion and ways of life, after the extinction of the non-bird dinosaurs. It points to a more complex story of competition between distinct mammal groups. The new research also highlights the importance of testing old and established ideas about evolution using the latest statistical tools.
"There were lots of exciting types of mammals in the time of dinosaurs that included gliding, swimming and burrowing species, but none of these mammals belonged to modern groups, they all come from earlier branches in the mammal tree." said Dr Elsa Panciroli, a researcher from the Oxford University Museum of Natural History and a co-author of the study. "These other kinds of mammals mostly became extinct at the same time as the non-avian dinosaurs, at which point modern mammals start to become larger, explore new diets and ways of life. From our research it looks like before the extinction it was the earlier radiations of mammals that kept the modern mammals out of these exciting ecological roles by outcompeting them".
Most of the mammal species alive today trace their origins to groups that expanded explosively 66 million years ago, when a mass extinction killed all non-bird dinosaurs. It was traditionally thought that, before the extinction, mammals lived in the shadow of the dinosaurs. They were supposedly prevented from occupying the niches that were already occupied by the giant reptiles, keeping the mammals relatively small and unspecialised in terms of diet and lifestyle. It appeared that they were only able to flourish after the dinosaurs' disappearance left these niches vacant.
However, new statistical methods were used to analyse how constrained different groups of mammals were in their evolution before and after the mass extinction. These methods identified the point where evolution stopped producing new traits and started producing features that had already evolved in other lineages. This allowed the researchers to identify the evolutionary "limits" placed on different groups of mammals, showing where they were being excluded from different niches by competition with other animals. The results suggest that it may not have been the dinosaurs that were placing the biggest constraints on the ancestors of modern mammals, but their closest relatives.
The study looked at the anatomy of all the different kinds of mammals living alongside dinosaurs, including the ancestors of modern groups, also known as therians. By measuring how frequently new features appeared, such as changes in the size and shape of their teeth and bones, and the pattern and timing of their appearance before and after the mass extinction, the researchers determined that the modern mammals were more constrained during the time of the dinosaurs than their close relatives. This meant that while their relatives were exploring larger body sizes, different diets, and novel ways of life such as climbing and gliding, they were excluding modern mammals from these lifestyles, keeping them small and generalist in their habits.
"This result makes very little sense if you assume that it was the dinosaurs constraining the therians" said Dr Neil Brocklehurst of the University of Oxford, who led the research. "There is no reason why the dinosaurs would be selectively competing with just these mammals and allowing others to prosper. It instead appears that the therians were being held back by these other groups of mammals."
The researchers suggest the extinction of other mammal groups was more important in paving the way for modern mammal success. As further evidence for this, the researchers looked at body size in different mammal groups. They discovered that both the smallest and largest mammals showed the same release from constraints following the dinosaur extinction, suggesting that size made little difference to their success.
Co-author Dr Gemma Benevento of the University of Birmingham said, "Most of the mammals that lived alongside the dinosaurs were less than 100g in body mass - that's smaller than any non-bird dinosaur. Therefore, these smallest mammals would probably not have been directly competing with dinosaurs. Despite this, small mammals show diversity increases after the extinction which are just as profound as those seen in larger mammals."
Dr Brocklehurst added, "Palaeontology is undergoing a revolution. We have greatly expanded the toolkit available to analyse large datasets and directly test our ideas about evolution. Most studies of the mammal radiation have focused on how fast they evolved, but analysing what limits there were on the evolution provides new perspectives. We have had to rethink many of our theories using these state-of-the-art approaches."
INFORMATION:
For further information:
Neil Brocklehurst
Department of Earth Sciences
University of Oxford
neil.brocklehurst@earth.ox.ac.uk
About Oxford University Museum of Natural History
Founded in 1860 as the centre for scientific study at the University of Oxford, the Museum of Natural History now holds the University's internationally significant collections of entomological, geological and zoological specimens. Housed in a stunning Pre-Raphaelite-inspired example of neo-Gothic architecture, the Museum's growing collections underpin a broad programme of natural environment research, teaching and public engagement.
http://www.oumnh.ox.ac.uk
http://www.morethanadodo.com
Notes to editors
The Research was funded by European Union's Horizon 2020 research and innovation program and the Deutsche Forschungsgemeinschaft (German Research Foundation). The full paper is published in Current Biology.
The full paper is published on the 17 May 16:00 (BST/GMT) as: Brocklehurst, N., Panciroli, E., Benevento, E. L. and Benson, R. B. J. 2021. Mammaliaform extinctions as a driver of the morphological radiation of Cenozoic mammals. Current Biology.
Before undergoing surgery, patients often go through a number of tests: blood work, sometimes a chest X-ray, perhaps tests to measure heart and lung function.
In fact, about half of patients who had one of three common surgical procedures done in Michigan between 2015 and the midway point of 2019 received at least one routine test beforehand.
That's according to new research in JAMA Internal Medicine from a collaboration between the University of Michigan-based Michigan Program on Value Enhancement (MPrOVE) and the Michigan Value Collaborative, a statewide initiative that focuses on improving medical and surgical quality.
Yet plenty of evidence suggests that preoperative testing is often unnecessary ...
The experimental heart failure drug omecamtiv mecarbil reduced heart failure hospitalizations by a greater margin among patients with more severely reduced ejection fraction, a measure indicating severe impairment in the heart's pumping ability, compared with those who had moderately reduced ejection fraction, according to research presented at the American College of Cardiology's 70th Annual Scientific Session.
Omecamtiv mecarbil works by improving the ability for heart muscle cells to contract and operates through a different biological pathway than any of the current heart failure medications. The research ...
One of the enduring mysteries of the COVID-19 pandemic is why most children tend to experience fewer symptoms than adults after infection with the coronavirus. The immune system response that occurs in the rare cases in which children experience life-threatening reactions after infection may offer an important insight, a Yale-led study published in the journal Immunity suggests.
While many children infected with the virus are asymptomatic or go undiagnosed, about one in 1,000 children experience multi-system inflammatory response (MIS-C) four to six weeks after confirmed infection with SARS-CoV-2, the virus that causes COVID-19. The condition ...
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic asthma, reducing the severity of its symptoms and thus significantly improving patient quality of life. Their research in animals has been published in the journal Nature Communications.
Asthma is a chronic disease affecting around 4 million people in France and 340 million worldwide. Allergic asthma is characterized by inflammation of the bronchial tubes and respiratory discomfort caused by the inhalation of allergens, most often dust mites. This exposure to dust mites and other allergens leads to ...
A randomized double-blind controlled trial of convalescent plasma for adults hospitalized with severe COVID-19 found that mortality at 28 days in the treatment arm was half the rate seen in the control arm (12.6% vs. 24.6%), although treatment was not associated with other improvements in clinical status.
The study was led by investigators from the Center for Infection and Immunity at Columbia University Mailman School of Public Health; Columbia University Irving Medical Center; ICAP at Columbia University; Instituto Nacional de Infectologia and Hospital Federal dos Servidores do Estado in Rio de Janeiro, Brazil; University of Washington; and New York Blood Center. The results are published in the Journal of Clinical Investigation.
According ...
Patients with heart failure with preserved ejection fraction who took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscle scarring compared with patients who received a placebo, based on findings from an early-phase trial presented at the American College of Cardiology's 70th Annual Scientific Session.
"Observational data suggests that heart muscle scarring, or fibrosis, is an important disease process for heart failure prognosis," said Chris Miller, MD, a cardiologist and National Institute for Health Research Clinician Scientist at the University ...
Patients with heart failure with reduced ejection fraction (HFrEF) did not have better health outcomes if they took sacubitril/valsartan combination therapy compared with valsartan alone, according to new data presented at the American College of Cardiology's 70th Annual Scientific Session.
Heart failure, a leading cause of hospitalization among adults over age 65, is a condition in which the heart becomes too weak to pump blood effectively to the rest of the body, causing fatigue and shortness of breath. For patients with severe heart failure, treatment options are limited to a mechanical heart pump or heart transplant. Doctors have sought ways to slow the progression of severe heart failure ...
The likelihood of people surviving COVID-19 in UK hospitals has been improving over time, a new study has found.
Research published in The Lancet Respiratory Medicine by the ISARIC Coronavirus Clinical Characterisation Consortium found that in-hospital mortality declined from 32% at the start of the first wave (Mar-Apr 2020) to 16% at the end of the first wave (Jun-Jul 2020).
In their study of 63,972 adults admitted to 247 UK hospitals the researchers found reductions in mortality were observed in all age groups, in all ethnic groups, for both sexes, and in patients with and without comorbidities. This improvement was ...
A group of Brazilian and Portuguese researchers observed a correlation between the presence of lead in the organism and a microRNA (miRNA) that could be associated with the mechanisms that regulate DNA methylation, a physiological process required to control gene expression and ensure that genes function properly.
The alterations were detected in blood cells from workers in automotive battery plants, which use lead as a raw material. Curiously, lead levels in blood samples from 85 volunteers – averaging 20 micrograms per deciliter of blood (20 μg/dl) – were lower than the acceptable ceiling defined in Brazilian law (60 μg/dl).
The study was supported by FAPESP and ...
A long noncoding RNA whose function was previously unknown turns out to play an important role in promoting the body's immune response against cancer and holds promise for enhancing the efficacy of anti-cancer immunotherapy.
That's according to new findings reported in Nature Cell Biology by researchers at the University of Michigan Rogel Cancer Center.
The group dubbed the RNA they identified LIMIT -- for long noncoding RNA inducing major histocompatibility complex class I and immunogenicity of tumor.
"LIMIT is easy to remember, but really it does the opposite. It stimulates immune functions against cancer," says senior study author Weiping Zou, M.D., Ph.D., the Charles B. de Nancrede Professor of Pathology, Immunology, Biology, and Surgery at U-M.
Only a small part of the human ...
